✦ LIBER ✦

Strategies of Immunosuppression for Liver Transplant Recipients With Hepatocellular Carcinoma

✍ Scribed by J.F. Castroagudín; E. Molina-Pérez; R. Ferreiro-Iglesias; E. Varo-Pérez

Book ID: 116936877
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 98 KB
Volume: 43
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2011.01.090

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus-based immunosuppression follow

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

✍ Michael A. Zimmerman; James F. Trotter; Michael Wachs; Tom Bak; Jeffrey Campsen; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Experience with sirolimus (SRL)-based immunosuppression following orthotopic liver transplantation (OLT) is rapidly accumulating. In combination with calcineurin inhibitors (CNIs), SRL may reduce the incidence of acute rejection and lower overall required drug levels. This study sought to quantify l

Recurrent Hepatocellular Carcinoma in Li

Recurrent Hepatocellular Carcinoma in Liver Transplant Recipients with Hepatitis C

✍ Ivan Zendejas-Ruiz, Alan W. Hemming, Chaoru Chen, Jason J. Schwartz, John B. Sor 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 236 KB

Immunosuppression with budesonide for li

Immunosuppression with budesonide for liver transplant recipients with severe infections

✍ Mamatha Bhat; Peter Ghali; Philip Wong; Victoria Marcus; René Michel; Marcelo Ca 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Liver transplantation for patients with

Liver transplantation for patients with hepatocellular carcinoma

✍ M.-C. Ho; Y.-M. Wu; R.-H. Hu; W.-J. Ko; P.-M. Yang; M.-Y. Lai; M.-H. Lin; H.-Y. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Sirolimus-based immunosuppression is ass

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma

✍ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of

Sirolimus-based immunosuppression in liv

Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis

✍ Wenhua Liang; Dongping Wang; Xiaoting Ling; Andrew Allen Kao; Yuan Kong; Yushu S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 786 KB

Sirolimus (SRL) is a novel immunosuppressant with antitumor properties. We performed a meta-analysis to determine whether SRL can improve patient survival and decrease the risks of tumor recurrence in patients with a pretransplant diagnosis of hepatocellular carcinoma (HCC). We searched databases fo